mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
Cyclopamine |
FIMM |
pan-cancer |
AAC |
0.42 |
0.004 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.004 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.005 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.006 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.007 |
mRNA |
Bicalutamide |
FIMM |
pan-cancer |
AAC |
0.45 |
0.007 |